| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 6.00B | 5.83B | 5.63B | 5.86B | 5.74B | 4.54B |
| Gross Profit | 1.67B | 5.00B | 4.83B | 5.02B | 1.46B | 3.82B |
| EBITDA | 1.65B | 1.75B | 1.94B | 2.19B | 2.34B | 1.62B |
| Net Income | 93.33M | 331.80M | 596.94M | 890.75M | 1.12B | 610.86M |
Balance Sheet | ||||||
| Total Assets | 21.62B | 20.48B | 19.06B | 18.10B | 17.30B | 14.65B |
| Cash, Cash Equivalents and Short-Term Investments | 1.03B | 1.70B | 2.06B | 2.75B | 2.74B | 1.20B |
| Total Debt | 8.06B | 7.24B | 6.33B | 6.17B | 7.19B | 5.83B |
| Total Liabilities | 13.87B | 12.98B | 11.89B | 11.60B | 11.35B | 9.80B |
| Stockholders Equity | 7.74B | 7.50B | 7.17B | 6.50B | 5.95B | 4.85B |
Cash Flow | ||||||
| Free Cash Flow | 1.00B | -2.00B | -1.54B | -994.29M | -190.30M | 93.92M |
| Operating Cash Flow | 1.59B | 1.45B | 1.45B | 1.73B | 1.95B | 1.54B |
| Investing Cash Flow | -2.47B | -2.89B | -2.05B | -2.42B | -1.87B | -1.13B |
| Financing Cash Flow | 880.71M | 895.11M | 66.53M | 59.80M | 1.43B | 287.35M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | $2.69B | 25.10 | 13.21% | 1.79% | 3.14% | -34.73% | |
67 Neutral | $9.67B | 21.79 | 16.39% | 1.75% | -0.07% | 4.18% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
59 Neutral | $9.50B | -53.96 | 1.22% | ― | 3.90% | -77.41% | |
56 Neutral | $4.45B | -34.53 | -0.26% | 1.79% | 28.39% | -105.83% | |
51 Neutral | $1.92B | -2.13 | 193.77% | ― | -6.02% | 74.03% | |
47 Neutral | $6.55B | -4.55 | 22.83% | ― | 0.72% | 69.91% |